Search Results | DrugBank Online

Displaying drugs 8051 - 8075 of 8134 in total

ACR-16 is under investigation by NeuroSearch. ACR16 has been successfully investigated in a Phase II multi-centre, randomised and placebo-controlled trial in patients with Huntington’s disease as well as in three Phase Ib studies within Huntington’s disease, Parkinson’s disease and schizophrenia respectively. ACR-16 is a dopamine stabilizer. ACR-16 is also being...

Investigational

Darapladib

Investigational

EHT 0202

EHT 0202 is developed to treat neurodegenerative disorders by ExonHit Therapeutics.

Investigational

Dovitinib

Dovitinib is an orally active small molecule that exhibits potent inhibitory activity against multiple RTKs involved in tumor growth and angiogenesis. Preclinical data show that dovitinib works to inhibit multiple kinases associated with different cancers, including acute myeloid leukemia (AML) and multiple myeloma. Chiron currently has three ongoing Phase I...

Investigational

Caldaret

Investigational

BG-777

BG-777 is an immunomodulator with proven efficacy against viral and bacterial infections in preclinical studies.

Investigational

Quisovalimab

Investigational

Labetuzumab

Labetuzumab is a humanized monoclonal antibody to carcinoembryonic antigen that inhibits tumor growth. It is used in radioimmunotherapy.

Investigational

Lanoteplase

Investigational

Tipapkinogene sovacivec

Investigational

DOTMP HO-166

DOTMP HO-166 is used in skeletal targeted radiotherapy (STR). SRT is designed to be used in combination with high-dose chemotherapy producing a direct therapeutic effect on the tumor sites in the bone plus a general bone-marrow effect to destroy myeloma cells in the bone marrow. It is an experimental therapy...

Investigational